Protagonist Therapeutics
PTGX
PTGX
139 hedge funds and large institutions have $1.19B invested in Protagonist Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
-9
Holders Change %
-6.08%
% of All Funds
2.2%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
20
Increased
54
Reduced
47
Closed
29
Calls
$52.9M
Puts
$14.7M
Net Calls
+$38.2M
Net Calls Change
+$11.8M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
$114M |
| 2 |
Morgan Stanley
New York
|
$31.7M |
| 3 |
CAC
Cowen and Company
New York
|
$17.1M |
| 4 |
State Street
Boston,
Massachusetts
|
$77.1M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
$13M |
